Drug discovery

#Automation #Biopharmaceuticals #Drug discovery #Sustainability

Key themes from ELRIG Drug Discovery 2025

This year’s ELRIG Drug Discovery event, which took place at the ACC in Liverpool, was intended as a celebration of the sector, uniting scientists, academics and industry professionals towards the common goal of improving human health. As such the theme for Drug Discovery 2025 was “A Festival of Life Science”… Read More

#News

#Drug discovery

Guide – Accelerate your imaging research with our updated protocols guide

This imaging protocol handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The guide covers main procedural steps to achieve your best results. Plan and optimise imaging experiments with clear, step-by-step procedural guidance. Master core and advanced techniques—from cell proliferation and… Read More

#Guides

#Cancer research #Drug discovery

Ebook: The impact of ADCs on drug discovery

Antibody-drug conjugates (ADCs) offer a targeted approach to cancer treatment, combining the specificity of antibodies with the potency of cytotoxic drugs, and have shown promise in improving patient outcomes. This eBook, sponsored by Abzena, explores the latest developments in the ADC field and the opportunities presented by next generation bioconjugates. Read More

#DDW eBooks

#Drug discovery #Multi-omics #Multiomics #Nanopore sequencing #QA/QC

Guide: Sequencing solutions for more confident decision-making

Discover sequencing solutions that can be applied from biomarker discovery through to final product quality control (QC) testing, consolidating multiple legacy assays with one platform — and enabling faster, more confident decision-making. In this new getting started Guide from Oxford Nanopore Technologies, you will: Find out how Oxford Nanopore… Read More

#News

#Drug discovery #Multi-omics #Multiomics #Nanopore sequencing #QA/QC

Oxford Nanopore sequencing solutions for biopharma

Discover sequencing solutions that can be applied from biomarker discovery through to final product quality control (QC) testing, consolidating multiple legacy assays with one platform — and enabling faster, more confident decision-making. In this new getting started guide, you will: Find out how Oxford Nanopore sequencing delivers the multiomic insight… Read More

#Guides #Resources

Lab automation
#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: AI-driven solutions streamline organoid workflows

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

T cells
#CAR-T #Cell therapy #Drug discovery #Webinar

Watch now: Technology & techniques to advance T cell therapy

Accelerate your CAR-T research. Watch this on-demand webinar ‘Next-generation tools for CAR-T and T cell therapy research’ to discover high-throughput imaging innovations for assessing cytotoxicity, T cell activation, and proliferation across 2D/3D models. Get proven methods and actionable insights to optimise constructs and scale up your translational assays. You… Read More

Webinar date:
Brought to you by Agilent
#News

T cells
#CAR-T #Cell therapy #Drug discovery #Webinar

Technology & techniques to advance your T cell therapy

Accelerate your CAR-T research. Discover high-throughput imaging innovations for assessing cytotoxicity, T cell activation, and proliferation across 2D/3D models. Get proven methods and actionable insights to optimise constructs and scale up your translational assays. You will learn: Ways to evaluate immune cell behavior and function Practical strategies for optimising your… Read More

Webinar date:
Brought to you by Agilent
#Webinars

#Drug discovery #Drug screening #Merck #Promega

Merck and Promega to co-develop drug discovery technologies 

Merck has entered a partnership with global life science service Promega Corporation to co-develop technologies advancing drug screening and discovery.  The agreement will bring together Merck’s expertise in organoids and synthetic chemistry with Promega’s assay and reporter technologies. The companies aim to develop assays… Read More

#Business & Investment #News

#Cryo-EM #cryo-microscopy #Drug discovery #eBook

eBook: Accelerating drug discovery with rational design

Structure-based drugs have two times the rate of clinical success at 50% of preclinical time and cost. A new eBook is now available which highlights recent examples of how cryo-EM and structural insights are being used across various therapeutic modalities to advance drug discovery pipelines. Download this eBook to… Read More

#News

#Cryo-EM #cryo-microscopy #Drug discovery #eBook

Accelerating drug discovery with rational design: Reducing time, cost, and risk with cryo-EM

This eBook highlights recent examples of how cryo-EM and structural insights are being used across various therapeutic modalities to advance drug discovery pipelines. Structure-based drugs have two times the rate of clinical success at 50% of preclinical time and cost. Download this eBook to see the impact of cryo-EM on:… Read More

#eBooks #Resources

#Drug discovery #Oncology #Radiopharmaceuticals #Theranostics

The promise of therapeutic radiopharmaceuticals

Denis R Beckford-Vera, Head of Radiopharmacology at Champions Oncology explores how radiopharmaceuticals can benefit from the use of patient-derived xenograft models.  The rising promise of radiopharmaceuticals Targeted radionuclide therapies (TRTs) are rapidly becoming a major force in oncology drug development. These agents combine a tumour-targeting molecule with a radioactive… Read More

#Exclusive Content

#Artificial intelligence (AI) #Cell Science #Drug discovery

Innovative AI software solutions driving biomarker research – custom webinar with Danaher Oct 2025

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. This webinar, hosted by DDW and supported by Danaher Life Sciences, explores how advanced platforms such as Genedata Profiler… Read More

#Webinars

London, UK
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

DDW Symposium: Panel line-up announced

Technology, market forces and new ways of working – the challenges facing drug discovery and how to overcome them: This will be the topic of the panel discussion at the DDW Turning Science into Business Symposium which will take place at the Francis Crick Institute in London on… Read More

#News

Covid-19 vaccine
#Covid-19 #DNA technology #Drug discovery #Immunology / Virology & Vaccines #Infectious diseases

The potential of DNA platforms for infectious disease vaccines 

Stacy R. Lindborg, President and Chief Executive Officer of IMUNON, discusses why research is needed to inform better strategies for infectious diseases such as Covid-19 and a new, multivalent non-viral DNA approach to vaccine development that has the potential to address continued unmet needs in the field. … Read More

#Exclusive Content